The GSPT1 gene, encoding the G1 to S phase transition 1 protein (also known as eukaryotic release factor 3a or eRF3a), is a crucial component of the translation termination machinery in eukaryotic cells. GSPT1, along with eRF1, forms the eukaryotic release factor complex that recognizes stop codons on messenger RNA (mRNA) and facilitates the release of the newly synthesized polypeptide from the ribosome, thereby terminating protein synthesis. This process is essential for the accurate and efficient translation of genetic information.Recent studies have highlighted the involvement of GSPT1 in various diseases, particularly in cancer. Overexpression of GSPT1 has been observed in several types of cancer, including lung, breast, and colorectal cancers, and is associated with poor prognosis. Inhibition of GSPT1 has been shown to induce apoptosis and reduce the viability of cancer cells, suggesting its potential as a therapeutic target. Additionally, GSPT1 has been implicated in the regulation of cellular senescence and the maintenance of stem cell properties.Understanding the multifaceted roles of GSPT1 in translation termination and other cellular processes is essential for elucidating its contributions to disease pathogenesis and for developing targeted therapeutic strategies.